- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
The new Differential Thermal Analysis (DTA) device presented in Iran Nano 2012 festival and exhibition earlier this month, came under mass-production by Iranian experts.
"This technology has extensive applications. We tried to produce this device since it did not exist in Iran. The main application of the device is analyzing the materials, specially nanomaterial. We week to produce another sample of the device that would be able to carry out the analysis in lower temperatures," the CEO of Pishtar Tajhizat Sazan Company said.
Differential thermal analysis device is one of the thermal identification and analysis devices, which is used for the determination of enthalpy changes and the value of specific heat capacity of materials at constant pressure in an exothermic or endothermic chemical reaction. The device operates based on the comparison of the thermal behavior of the reference material and the sample.
The device has many applications in medical and food industries. Specific application of the device is related to ceramic materials, glaze, and cement. In this method, thermal behavior study is used as one of the main techniques as well as weight change analysis and the amount of material energy transference during thermal differentiations.
For more information, please click here
Copyright © Fars News AgencyIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Leti IEDM 2016 Paper Clarifies Correlation between Endurance, Window Margin and Retention in RRAM for First Time: Paper Presented at IEDM 2016 Offers Ways to Reconcile High-cycling Requirements and Instability at High Temperatures in Resistive RAM December 6th, 2016
Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016
UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016
Nanobiotix Provides Update on Global Development of Lead Product NBTXR3: Seven clinical trials across the world: More than 2/3 of STS patients recruited in the “act.in.sarc” Phase II/III trial: Phase I/II prostate cancer trial now recruiting in the U.S. November 28th, 2016
Controlled electron pulses November 30th, 2016
New Agricultural Research Center Debuts at UCF October 12th, 2016